(1)
Vadakke Puthiyottil, S.; Edayattil, A.; N K, S. Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review. apjcc 2026, 11, 481-488.